330 related articles for article (PubMed ID: 8187833)
1. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
Barth H; Kinzel V
Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor rapidly impairs activation of p34cdc2 protein kinase in HeLa cells at the G2-M boundary.
Barth H; Kinzel V
J Cell Physiol; 1995 Jan; 162(1):44-51. PubMed ID: 7814450
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
4. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester.
Barth H; Hoffmann I; Klein S; Kaszkin M; Richards J; Kinzel V
J Cell Physiol; 1996 Sep; 168(3):589-99. PubMed ID: 8816913
[TBL] [Abstract][Full Text] [Related]
5. Radiation with 1 Gy prevents the activation of the mitotic inducers mitosis-promoting factor (MPF) and cdc25-C in HeLa cells.
Barth H; Hoffmann I; Kinzel V
Cancer Res; 1996 May; 56(10):2268-72. PubMed ID: 8625296
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of protein phosphatase 2A activity in HeLa cells at the G2-mitosis transition and unscheduled reactivation induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA).
Klingler-Hoffmann M; Barth H; Richards J; König N; Kinzel V
Eur J Cell Biol; 2005 Aug; 84(8):719-32. PubMed ID: 16180310
[TBL] [Abstract][Full Text] [Related]
8. Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase.
Baratte B; Meijer L; Galaktionov K; Beach D
Anticancer Res; 1992; 12(3):873-80. PubMed ID: 1320360
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of MPF and histone H1 kinase activity differ during the G2- to M-phase transition in mouse oocytes.
Jung T; Moor RM; Fulka J
Int J Dev Biol; 1993 Dec; 37(4):595-600. PubMed ID: 8180003
[TBL] [Abstract][Full Text] [Related]
10. [From ovocyte to biochemistry of the cell cycle].
Ozon R
Verh K Acad Geneeskd Belg; 1991; 53(4):365-85. PubMed ID: 1659057
[TBL] [Abstract][Full Text] [Related]
11. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle.
Gautier J; Matsukawa T; Nurse P; Maller J
Nature; 1989 Jun; 339(6226):626-9. PubMed ID: 2543932
[TBL] [Abstract][Full Text] [Related]
12. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence.
Jantzen H; Schulze I
Dev Biol; 1994 Nov; 166(1):311-22. PubMed ID: 7958455
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.
Lock RB
Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112
[TBL] [Abstract][Full Text] [Related]
14. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates.
Rialet V; Meijer L
Anticancer Res; 1991; 11(4):1581-90. PubMed ID: 1660692
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
16. MPF components and meiotic competence in growing pig oocytes.
Christmann L; Jung T; Moor RM
Mol Reprod Dev; 1994 May; 38(1):85-90. PubMed ID: 8049069
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity.
Eblen ST; Fautsch MP; Burnette RJ; Snyder M; Leof EB
Cancer Res; 1995 May; 55(9):1994-2000. PubMed ID: 7728771
[TBL] [Abstract][Full Text] [Related]
18. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells.
Shen SC; Huang TS; Jee SH; Kuo ML
Cell Growth Differ; 1998 Jan; 9(1):23-9. PubMed ID: 9438385
[TBL] [Abstract][Full Text] [Related]
19. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
Van Dolah FM; Ramsdell JS
J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
[TBL] [Abstract][Full Text] [Related]
20. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein.
Strausfeld U; Labbé JC; Fesquet D; Cavadore JC; Picard A; Sadhu K; Russell P; Dorée M
Nature; 1991 May; 351(6323):242-5. PubMed ID: 1828290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
